These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 31629643

  • 1. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A.
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [Abstract] [Full Text] [Related]

  • 2. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P, Fabbri LM, Bush A.
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [Abstract] [Full Text] [Related]

  • 3. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
    Shteinberg M, Schneer S, Lavon O, Adir Y.
    Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
    [Abstract] [Full Text] [Related]

  • 4. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K, Kastelik J, Morjaria JB.
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [Abstract] [Full Text] [Related]

  • 5. Use of macrolides in lung diseases: recent literature controversies.
    Silva Filho LV, Pinto LA, Stein RT.
    J Pediatr (Rio J); 2015 Jun; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 7. Rational use of mucoactive medications to treat pediatric airway disease.
    Linssen RSN, Ma J, Bem RA, Rubin BK.
    Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
    [Abstract] [Full Text] [Related]

  • 8. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
    Shimizu T, Suzaki H.
    Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
    [Abstract] [Full Text] [Related]

  • 9. Anti-inflammatory effects of macrolides in lung disease.
    Jaffé A, Bush A.
    Pediatr Pulmonol; 2001 Jun; 31(6):464-73. PubMed ID: 11389580
    [Abstract] [Full Text] [Related]

  • 10. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
    Li W, Qin Z, Gao J, Jiang Z, Chai Y, Guan L, Chen Y.
    Chron Respir Dis; 2019 Jun; 16():1479972318790269. PubMed ID: 30101613
    [Abstract] [Full Text] [Related]

  • 11. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.
    Rubin BK, Henke MO.
    Chest; 2004 Feb; 125(2 Suppl):70S-78S. PubMed ID: 14872003
    [Abstract] [Full Text] [Related]

  • 12. Role of macrolide therapy in chronic obstructive pulmonary disease.
    Martinez FJ, Curtis JL, Albert R.
    Int J Chron Obstruct Pulmon Dis; 2008 Feb; 3(3):331-50. PubMed ID: 18990961
    [Abstract] [Full Text] [Related]

  • 13. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R.
    J Med Chem; 2012 Jul 12; 55(13):6111-23. PubMed ID: 22697905
    [Abstract] [Full Text] [Related]

  • 14. Macrolides and airway inflammation in children.
    Shinkai M, Rubin BK.
    Paediatr Respir Rev; 2005 Sep 12; 6(3):227-35. PubMed ID: 16153572
    [Abstract] [Full Text] [Related]

  • 15. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P.
    Drugs; 2007 Sep 12; 67(7):965-74. PubMed ID: 17488142
    [Abstract] [Full Text] [Related]

  • 16. Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
    Brusselle GG.
    Thorax; 2015 May 12; 70(5):401-3. PubMed ID: 25870311
    [No Abstract] [Full Text] [Related]

  • 17. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
    El Boustany P, Gachelin E, Colomban C, Cernoia J, Sudour P, Carsin A, Dubus JC.
    Pediatr Pulmonol; 2019 Apr 12; 54(4):487-496. PubMed ID: 30652424
    [Abstract] [Full Text] [Related]

  • 18. Which patients with respiratory disease need long-term azithromycin?
    Alchakaki A, Cramer C, Patterson A, Soubani AO.
    Cleve Clin J Med; 2017 Oct 12; 84(10):755-758. PubMed ID: 28985171
    [No Abstract] [Full Text] [Related]

  • 19. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases.
    Serisier DJ.
    Lancet Respir Med; 2013 May 12; 1(3):262-74. PubMed ID: 24429132
    [Abstract] [Full Text] [Related]

  • 20. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S, Egan JJ.
    Expert Rev Anti Infect Ther; 2005 Dec 12; 3(6):923-30. PubMed ID: 16307505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.